Randomised Clinical Trial for Postoperative Complications after Ex-PRESS Implantation versus Trabeculectomy with 2-Year Follow-Up
- PMID: 30385884
- PMCID: PMC6212395
- DOI: 10.1038/s41598-018-34627-w
Randomised Clinical Trial for Postoperative Complications after Ex-PRESS Implantation versus Trabeculectomy with 2-Year Follow-Up
Abstract
We compared complications between Ex-PRESS implantation and trabeculectomy for 2 years after surgery. Sixty-four open-angle glaucoma eyes were randomly assigned to treatment with trabeculectomy (n = 32) or Ex-PRESS implantation (n = 32). The primary outcomes were postoperative complications, including reduction of the endothelial cell density (ECD) of the cornea, cataract progression and the frequency of other late postoperative complications. The Ex-PRESS group had significantly greater reduction of postoperative corneal ECD than the trabeculectomy group did at 2 years after surgery (P = 0.026). Among the corneal areas measured using specular microscopy, the superior area, where the Ex-PRESS tube was inserted, had significantly more severe corneal ECD reduction than the inferior area after 2 years (-17.6% in superior area and -11.7% in inferior area, P = 0.04). More cataract progression occurred in the trabeculectomy group than in the Ex-PRESS group (P = 0.04). Twelve eyes (37.5%) in the trabeculectomy group and 4 eyes (12.5%) in the Ex-PRESS group underwent cataract surgery (P = 0.019). The total number of other postoperative complications between 3 months and 2 years was significantly higher in the trabeculectomy group than in the Ex-PRESS group (P = 0.02). Although Ex-PRESS implantation might be associated with an increased rate of corneal endothelial cell loss compared with trabeculectomy, it is beneficial for preventing cataract progression after filtering surgery.
Conflict of interest statement
M.I. is responsible for submitting a competing financial interest statement on behalf of all authors of the paper. M.I.’s work has been partially funded by Sumitomo, HOYA, Novartis, Pfizer, Alcon, Senju, Santen, Kowa, MSD, Otsuka, and AMO. The other authors declare no competing interests.
Figures
References
-
- Austin MW, Wishart PK. Reformation of the anterior chamber following trabeculectomy. Ophthalmic. Surg. 1993;24:461–466. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
